ORPHA:342
Familial Mediterranean fever
Also known as: Benign paroxysmal peritonitis · Benign recurrent polyserositis · FMF · Familial paroxysmal polyserositis · Periodic disease
Publications
13,770
96.1th percentile
Trials
30
Interventional, condition-specific
Researchers
1,017
Distinct authors in sample
Gene link
MEFV
Definitive
Readiness
6/6
Stages with a signal
Clinical definition (Orphanet)
Familial Mediterranean fever (FMF) is an autoinflammatory disorder characterized by recurrent short episodes of fever and serositis resulting in pain in the abdomen, chest, joints and muscles.
How rare: >1 / 1000
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0018088
- MeSH:D010505
- UMLS:C0031069
- NCIT:C84707
Additional Mondo synonyms (5)
Fiebre mediterránea familiar · benign paroxysmal peritonitis · benign recurrent polyserositis · familial paroxysmal polyserositis · periodic disease
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
6/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedPresent
Definitive — MEFV
- LiteraturePresent
13,770 matched papers (7,230 in last 10 years) Source
- Phenotype characterisedPresent
93 HPO annotations (e.g. Chest pain; Pleuritis; Renal insufficiency) Source
- Animal modelPresent
4 genotype models (Mus musculus) Source
- Orphan designationPresent
3 FDA designations (1 FDA orphan-indication approval) — e.g. rilonacept Source
- Interventional trialPresent
30 matched on ClinicalTrials.gov (7 recruiting in sample)
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Yes — we know a specific gene responsible (MEFV).
GenCC classification: Definitive.
Phenotypes (Monarch / HPO)
93
Associated phenotypes · MONDO:0018088
- Chest pain
- Pleuritis
- Renal insufficiency
- Proteinuria
- Arthralgia
Showing 5 of 93 — open Monarch for the full list.
Animal models (Monarch / Alliance)
4
Model associations linked to this Mondo ID
- Mefvtm3.1(MEFV)Chae/Mefvtm3.1(MEFV)Chae [background:] B6.129S6-Mefvtm3.1(MEFV)Chae·MGI:5007926·Mus musculus
- Mefvtm5.1(MEFV)Chae/Mefvtm5.1(MEFV)Chae [background:] B6.129S6-Mefvtm5.1(MEFV)Chae·MGI:5007929·Mus musculus
- Mefvtm4.1(MEFV)Chae/Mefvtm4.1(MEFV)Chae [background:] B6.129S6-Mefvtm4.1(MEFV)Chae·MGI:5007927·Mus musculus
- Mefvtm1Chae/Mefvtm1Chae [background:] either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * C57BL/6)·MGI:2655804·Mus musculus
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
3
Designations · 1 with FDA orphan-indication approval
- FDA rilonaceptFamilial Mediterranean Fever · 2013-01-09 · Not FDA Approved for Orphan Indication
- FDA canakinumab (ILARIS)Familial Mediterranean Fever · 2013-12-05
- FDA colchicine (Colcrys)Familial Mediterranean Fever · 2007-09-25
Sources: FDA OOPD · EMA orphan designations
Open Targets candidates
7
Drugs / clinical candidates · MONDO_0018088
- ANAKINRA·phase 3
- GOFLIKICEPT·phase 2
- RILONACEPT·phase 2
- TOCILIZUMAB·phase 2
- VIMNERIXIN·phase 2
- CANAKINUMAB·approval
- COLCHICINE·approval
CTD chemicals (MyDisease.info)
4 associated chemicals · 6 pathways. Therapeutic evidence is listed first when present — not a treatment recommendation.
- Azathioprine · therapeutic
- azelastine · therapeutic
- Colchicine · therapeutic
- Methotrexate · therapeutic
Pathways: NOD-like receptor signaling pathway; Innate Immune System; Immune System; Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways; Inflammasomes; The NLRP3 inflammasome
Literature
Is anyone studying this?
13,770
13,770 papers — among the better-studied rare conditions, though still a fraction of common-disease literature (breast cancer: over 700,000). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
13,770 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
7,230 in the last 10 years · medium confidence · 96.1th percentile (publications denominator)
Phrase hits: 11,142 · MeSH hits: 0
Who's working on it?
1,017
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Ugurlu S8 papers · 2026
Division of Rheumatology, Department of Internal Medicine, Cerrahpaşa Faculty of Medicine, İstanbul University-Cerrahpaşa, İstanbul, Türkiye.
Papers in Europe PMC - 02Özçelik E6 papers · 2026
Division of Pediatric Rheumatology, Department of Pediatrics, University of Health Sciences, Ankara Bilkent City Hospital Ankara, Türkiye.
Papers in Europe PMC - 03Çelikel Acar B5 papers · 2026
Division of Pediatric Rheumatology, Department of Pediatrics, University of Health Sciences, Ankara Bilkent City Hospital Ankara, Türkiye.
Papers in Europe PMC - 04Çelikel E5 papers · 2026
Division of Pediatric Rheumatology, Department of Pediatrics, University of Health Sciences, Ankara Bilkent City Hospital Ankara, Türkiye.
Papers in Europe PMC - 05Ertem Ş5 papers · 2026
Division of Pediatric Rheumatology, Department of Pediatrics, University of Health Sciences, Ankara Bilkent City Hospital Ankara, Türkiye.
Papers in Europe PMC - 06Ozen S5 papers · 2026
Division of Pediatric Rheumatology, Department of Pediatrics, Hacettepe University School of Medicine, Ankara, Turkey.
Papers in Europe PMC - 07Öztürk D5 papers · 2026
Division of Pediatric Rheumatology, Department of Pediatrics, University of Health Sciences, Ankara Bilkent City Hospital Ankara, Türkiye.
Papers in Europe PMC - 08Ozturk K5 papers · 2026
Department of Paediatrics, Division of Rheumatology, Istanbul Medeniyet University, Istanbul, Turkey.
Papers in Europe PMC - 09Sözeri B5 papers · 2026
Department of Pediatric Rheumatology, Ümraniye Training and Research Hospital, University of Health Sciences, Istanbul, Türkiye.
Papers in Europe PMC - 10Tunce E5 papers · 2026
Department of Pediatric Rheumatology, Ümraniye Training and Research Hospital, University of Health Sciences, Istanbul, Türkiye.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
30
interventional trials for this specific condition
30 interventional trials matched this specific condition name; 7 currently recruiting in our sample.
Data as of 11 September 2026 · last trial check 28 July 2026
30 interventional trials — more than 77.2% of diseases in the trials denominator have none at all (5501 of 7126; this disease is at the 96th percentile).
medium confidence · 96th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
30 interventional trials matched after quoted-phrase search and title/condition post-filter.
- NCT06336733·RECRUITING·Randomized Controlled Trial in Patients on Long-term Colchicine With Colchicine-resistant Familial Mediterranean Fever (FMF) to Evaluate the Efficacy of On-demand Anakinra Treatment for Painful Attacks in Patients Who Refuse Continuous Daily Therapy
Not reviewed·Conditions: FMF·Matched via name phrase
- NCT07130318·RECRUITING·Mediterranean Diet in Familial Mediterranean Fever: Is Fatty Liver Affected by Addition of Aerobic Exercise
Not reviewed·Conditions: Familial Mediterranean Fever · Non-Alcoholic Fatty Liver Disease·Matched via name phrase
- NCT07130305·RECRUITING·is There an Effect of Adding Body Vibration to Intake of Vitamin D on Some Outcomes of Familial Mediterranean Fever
Not reviewed·Conditions: Familial Mediterranean Fever·Matched via name phrase
- NCT06743152·NOT YET RECRUITING·Comparison of the Effects of Synchronous and Asynchronous Telerehabilitation in Patients with Juvenile Familial Mediterranean Fever
Not reviewed·Conditions: Familial Mediterranean Fever (FMF ) · Exercise · Telerehabilitation·Matched via name phrase
- NCT07013045·ENROLLING BY INVITATION·Comparing Structured Neuromuscular Exercise and Exergaming Program in Adolescents With Familial Mediterranean Fever
Not reviewed·Conditions: Familial Mediterranean Fever (FMF )·Matched via name phrase
- NCT05190991·RECRUITING·Safety and Efficacy of RPH-104 Used to Prevent Recurrent Fever Attacks in Adult Patients With Colchicine Resistant or Colchicine Intolerant Familial Mediterranean Fever
Not reviewed·Conditions: Familial Mediterranean Fever · FMF·Matched via name phrase
- NCT07129538·RECRUITING·Outcomes of Inspiratory Muscle Training in FMF Adolescents
Not reviewed·Conditions: Familial Mediterranean Fever·Matched via name phrase
Observational and natural-history studies
33 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT07077473·RECRUITING·Observing the Efficacy and Safety of Different Drugs Used in Real-world Familial Mediterranean Fever (FMF) Cases
Not reviewed·Conditions: Familial Mediterranean Fever (FMF )·Matched via name phrase
- NCT07517250·RECRUITING·A Study on the Use of Canakinumab Among Familial Mediterranean Fever and Still's Disease Patients
Not reviewed·Conditions: Familial Mediterranean Fever · Still Disease · Systemic Juvenile Idiopathic Arthritis · Adult-Onset Still Disease·Matched via name phrase
- NCT07329556·NOT YET RECRUITING·Skin Autofluorescence Assessment of Advanced Glycation End Products in Rheumatic Diseases
Not reviewed·Conditions: Rheumatoid Arthritis (RA · Ankylosing Spondylitis · Psoriatic Arthritis · Reactive Arthritis (ReA)·Matched via name phrase
- NCT07248059·NOT YET RECRUITING·Prevalence of Oral Findings in Egyptian Patients Diagnosed With Familial Mediterranean Fever
Not reviewed·Conditions: Familial Mediterranean Fever (FMF ) and Oral Findings·Matched via name phrase
- NCT06838143·RECRUITING·Ilaris NIS in Korea
Not reviewed·Conditions: Hereditary Periodic Fever Syndromes · Cryopyrin-associated Periodic Syndromes (CAPS) · Colchicine Resistance Familial Mediterranean Fever (crFMF) · TNF Receptor Associated Periodic Syndrome (TRAPS)·Matched via name phrase
- NCT06974942·NOT YET RECRUITING·Physical Activity in Adolescents With Familial Mediterranean Fever
Not reviewed·Conditions: Familial Mediterranean Fever (FMF )·Matched via name phrase
- NCT00001373·RECRUITING·Familial Mediterranean Fever and Related Disorders: Genetics and Disease Characteristics
Not reviewed·Conditions: Familial Mediterranean Fever (FMF) · Autoinflammation · Periodic Fever · Fever·Matched via name phrase
- NCT06583304·NOT YET RECRUITING·Hematological Indices in Pediatric Diagnosed With Familial Mediterranean Fever
Not reviewed·Conditions: Familial Mediterranean Fever (FMF )·Matched via name phrase
- NCT06725849·NOT YET RECRUITING·Barriers to Physical Activity in Familial Mediterranean Fever
Not reviewed·Conditions: Familial Mediterranean Fever (FMF )·Matched via name phrase
- NCT07617558·NOT YET RECRUITING·Validity and Reliability of the International Physical Fitness Questionnaire and the Self-Perceived Health-Related Physical Fitness Questionnaire in Children and Adolescents With JIA and FMF
Not reviewed·Conditions: Juvenile Idiopathic Arthritis · Familial Mediterranean Fever·Matched via name phrase
- NCT06705673·NOT YET RECRUITING·Gait Profile and Variables in Pediatric Rheumatic Disease Using a Smart Insole System
Not reviewed·Conditions: Juvenile Idiopathic Arthritis (JIA) · Familial Mediterranean Fever (FMF ) · Healthy Controls·Matched via name phrase
- NCT07439341·NOT YET RECRUITING·AGE and CALLY Index in Familial Mediterranean Fever
Not reviewed·Conditions: Familial Mediterranean Fever·Matched via name phrase
- NCT06338891·RECRUITING·Can Gluten/Wheat or Other Foods be Responsible for FMF Attacks
Not reviewed·Conditions: Familial Mediterranean Fever · Non-celiac Gluten Sensitivity·Matched via name phrase
- NCT07212764·ENROLLING BY INVITATION·Mobile App-Based Infection Monitoring in Familial Mediterranean Fever
Not reviewed·Conditions: Familial Mediterranean Fever (FMF ) · Infection · Mobile Application·Matched via name phrase
- NCT06830213·NOT YET RECRUITING·Investigation of the Validity, Reliability and Responsiveness of the BETY-BQ in FMF
Not reviewed·Conditions: Familial Mediterranean Fever (FMF )·Matched via name phrase
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 2 · after dedupe 2 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 2 · dropped 0 · fetched 2026-07-29
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (2)
- ctis·2023-506721-11-00·Authorised, ongoing·Randomized controlled trial in patients on long-term colchicine with colchicine-resistant familial Mediterranean fever (FMF) to evaluate the efficacy of on-demand Anakinra treatment for painful attacks in patients who refuse continuous daily therapy (KIN-ATTACK-FMF).
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN12958502·No longer recruiting·Inhibition of cardiac fibrosis by colchicine in acute myocardial infarction
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Familial Mediterranean fever — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
("Familial Mediterranean fever" OR "Benign paroxysmal peritonitis" OR "Benign recurrent polyserositis" OR "Familial paroxysmal polyserositis" OR "Periodic disease" OR "Fiebre mediterránea familiar") OR ("MEFV" OR "MEFV syndrome" OR "MEFV-related")ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Familial Mediterranean fever" OR "Benign paroxysmal peritonitis" OR "Benign recurrent polyserositis" OR "Familial paroxysmal polyserositis" OR "Periodic disease" OR "Fiebre mediterránea familiar"
Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 30 interventional · 33 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Synonyms dropped by stoplist: FMF
Confidence reasoning
- Preferred label is multi-word and distinctive
- 1 synonym(s) dropped by stoplist (may under-count)
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-26T13:29:06.073Z
